| Code | CSB-RA169564A0HU |
| Size | US$210 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
| Application | Recommended Dilution |
|---|---|
| IHC | 1:50-1:200 |
| FC | 1:50-1:200 |
SEC62 is a critical component of the Sec61 translocon complex, playing an essential role in the post-translational translocation of proteins across the endoplasmic reticulum membrane. This protein has garnered significant research attention due to its involvement in cellular stress responses and its emerging role in cancer biology, where SEC62 amplification and overexpression have been linked to tumor progression and metastasis in several malignancies.
This recombinant monoclonal antibody, generated against a synthetic peptide derived from human SEC62, offers the reproducibility and consistency that demanding research applications require. As a sequence-defined recombinant clone, it eliminates the lot-to-lot variability inherent in traditional hybridoma-derived antibodies, ensuring your experimental results remain comparable across extended studies and collaborative projects.
The antibody has been validated for immunohistochemistry and flow cytometry applications, providing flexibility across different experimental workflows. IHC validation demonstrates clear detection in paraffin-embedded human kidney tissue and human colorectal cancer specimens at 1:100 dilution using citrate buffer antigen retrieval, making it suitable for both normal tissue characterization and oncology research. Flow cytometry validation in MCF-7 breast cancer cells confirms its utility for intracellular detection of SEC62 in fixed and permeabilized samples, with clear separation from isotype control.
Supplied in a glycerol-containing buffer optimized for long-term stability at -20°C or -80°C, this antibody is well-suited for researchers investigating ER stress pathways, protein translocation mechanisms, or the role of SEC62 in cancer development and progression. Its validated performance in human tissues and cancer cell lines makes it a reliable tool for both basic research and translational oncology studies.
There are currently no reviews for this product.